Research & Development
Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment
21 August 2026 - Global oncology company Nuvation Bio Inc (NYSE:NUVB) announced on Thursday that the US Food and Drug Administration (FDA) has granted Fast Track Designation for safusidenib, the compa...
Maverix Medical's Narwhal Cryo System receives FDA 510(k) clearance
21 August 2026 - Maverix Medical, a healthcare company focused on improving the diagnosis and treatment of lung cancer, announced on Thursday that the US Food and Drug Administration (FDA) granted 510...
Implantica's RefluxStop receives US FDA approval
21 August 2026 - Medical technology company Implantica AG (Nasdaq First North Premier Growth Market: IMP A SDB) announced on Thursday that the US Food and Drug Administration (FDA) has granted Premark...
Lupin's VISUfarma signs European licensing deal for presbyopia therapy YUVEZZI
20 August 2026 - Indian pharmaceutical companies Lupin Limited (BSE: 500257; NSE: LUPIN) said on Thursday it has agreed an exclusive licensing deal with commercial-stage ophthalmic pharmaceutical comp...
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
19 August 2026 - Aqua Medical Inc, a clinical-stage medical technology company advancing Endoscopic Metabolic Restoration, announced on Tuesday the treatment of the first West Coast patient (second ov...
Harbour BioMed IND for HBM7004 approved by China's NMPA
18 August 2026 - Global biopharmaceutical company Harbour BioMed (HKEX: 02142), which develops antibody therapeutics in immunology and oncology, said on Tuesday that China's National Medical Prod...